# Safety, Tolerability, & Pharmacokinetics Study of Single & Multiple Inhaled Doses of Imatinib Inhalation Solution

> **NCT04903730** · PHASE1 · COMPLETED · sponsor: **Aerami Therapeutics** · enrollment: 83 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** AER-901 Solution for Nebulization
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04903730
- **Lead sponsor:** Aerami Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-24
- **Primary completion:** 2022-12-02
- **Final completion:** 2022-12-02
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2022-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04903730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04903730, "Safety, Tolerability, & Pharmacokinetics Study of Single & Multiple Inhaled Doses of Imatinib Inhalation Solution". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT04903730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*